Pathophysiologic mechanisms linking impaired cardiovascular health and neurologic dysfunction: The year in review

Cleveland Clinic Journal of Medicine

Volumn 77, Issue SUPPL. 3, 2010, Pages

  Park, Ki E ^a   Pepine, Carl J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN; SEROTONIN TRANSPORTER;

CARDIOVASCULAR DISEASE; CYTOLOGY; DEPRESSION; GENETIC PREDISPOSITION; GENETICS; HEART MUSCLE ISCHEMIA; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MENTAL STRESS; METABOLISM; MIGRAINE; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; REVIEW; STROKE; THROMBOCYTE; VASCULAR ENDOTHELIUM;

BLOOD PLATELETS; CARDIOVASCULAR DISEASES; DEPRESSION; ENDOTHELIUM, VASCULAR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MIGRAINE DISORDERS; MYOCARDIAL ISCHEMIA; NERVOUS SYSTEM DISEASES; PITUITARY-ADRENAL SYSTEM; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STRESS, PSYCHOLOGICAL; STROKE;

EID: 77954702255     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.77.s3.07     Document Type: Review

References (39)

1. McCaffery JM, Duan QL, Frasure-Smith N, et al. Genetic predictors of depressive symptoms in cardiac patients. Am J Med Genet B Neuropsychiatr Genet 2009; 150B:381-388.
2. Cohen Z, Bouchelet I, Olivier A, et al. Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: molecular and pharmacologic characterization. J Cereb Blood Flow Metab 1999; 19:908-917.
3. Kring SI, Werge T, Holst C, et al. Polymorphisms of serotonin receptor 2A and 2C genes and COMT in relation to obesity and type 2 diabetes. PLoS One 2009; 4:e6696.
4. Ni W, Watts SW. 5-Hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT). Clin Exp Pharmacol Physiol 2006; 33:575-583.
5. Nefedov VP, Nefedova VV, Kononykhina VS, et al. The effect of serotonin on the hematopoietic stem cells of the bone marrow [in Russian]. Biull Eksp Biol Med 1991; 112:488-489.
6. Pakala R, Willerson JT, Benedict CR. Mitogenic effect of serotonin on vascular endothelial cells. Circulation 1994; 90:1919-1926.
7. Yang M, Li K, Ng PC, et al. Promoting effects of serotonin on hematopoiesis: ex vivo expansion of cord blood CD34+ stem/progenitor cells, proliferation of bone marrow stromal cells, and antiapoptosis. Stem Cells 2007; 25:1800-1806.
8. Cloez-Tayarani I, Petit-Bertron AF, Venters HD, et al. Differential effect of serotonin on cytokine production in lipopolysac-charide-stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors. Int Immunol 2003; 15:233-240.
9. Hoefgen B, Schulze TG, Ohlraun S, et al. The power of sample size and homogenous sampling: association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder. Biol Psychiatry 2005; 57:247-251.
10. Nakatani D, Sato H, Sakata Y, et al. Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am Heart J 2005; 150:652-658.
11. Brummett BH, Boyle SH, Siegler IC, et al. Effects of environmental stress and gender on associations among symptoms of depression and the serotonin transporter gene linked polymorphic region (5-HTTLPR). Behav Genet 2008; 38:34-43.
12. Fumeron F, Betoulle D, Nicaud V, et al. Serotonin transporter gene polymorphism and myocardial infarction: Etude Cas-Témoins de l'Infarctus du Myocarde (ECTIM). Circulation 2002; 105:2943-2945.
13. Phillips-Bute B, Mathew JP, Blumenthal JA, et al. Relationship of genetic variability and depressive symptoms to adverse events after coronary artery bypass graft surgery. Psychosom Med 2008; 70:953-959.
14. Greenberg BD, Tolliver TJ, Huang SJ, et al. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 1999; 88:83-87.
15. Su S, Zhao J, Bremner JD, et al. Serotonin transporter gene, depressive symptoms, and interleukin-6. Circ Cardiovasc Genet 2009; 2:614-620.
16. 1-adrenergic receptor genetic polymorphism with mental stress-induced myocardial ischemia in patients with coronary artery disease. Arch Intern Med 2008; 168:763-770.
17. Victor TW, Hu X, Campbell J, et al. Association between migraine, anxiety and depression. Cephalalgia 2009; Jul 9 [Epub ahead of print].
18. MacClellan LR, Howard TD, Cole JW, et al. Relation of candidate genes that encode for endothelial function to migraine and stroke: the Stroke Prevention in Young Women study. Stroke 2009; 40:e550-e557.
19. Tikka-Kleemola P, Kaunisto MA, Hamalainen E, et al. Genetic association study of endothelin-1 and its receptors EDNRA and EDNRB in migraine with aura. Cephalalgia 2009; 29:1224-1231.
20. Tomfohr LM, Martin TM, Miller GE. Symptoms of depression and impaired endothelial function in healthy adolescent women. J Behav Med 2008; 31:137-143.
21. Katayama Y, Battista M, Kao WM, et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 2006; 124:407-421.
22. Fischer JC, Kudielka BM, von Kanel R, et al. Bone-marrow derived progenitor cells are associated with psychosocial determinants of health after controlling for classical biological and behavioral cardiovascular risk factors. Brain Behav Immun 2009; 23:419-426.
23. Baskin SM, Smitherman TA. Migraine and psychiatric disorders: comorbidities, mechanisms, and clinical applications. Neurol Sci 2009; 30(suppl 1):S61-S65.
24. Lee S-T, Chu K, Jung KH, et al. Decreased number and function of endothelial progenitor cells in patients with migraine. Neurology 2008; 70:1510-1517.
25. Sobrino T, Hurtado O, Moro MA, et al. The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome. Stroke 2007; 38:2759-2764.
26. Jickling G, Salam A, Mohammad A, et al. Circulating endothelial progenitor cells and age-related white matter changes. Stroke 2009; 40:3191-3196.
27. Parakh K, Sakhuja A, Bhat U, et al. Platelet function in patients with depression. South Med J 2008; 101:612-617.
28. Aschbacher K, Mills PJ, von Känel R, et al. Effects of depressive and anxious symptoms on norepinephrine and platelet P-selectin responses to acute psychological stress among elderly caregivers. Brain Behav Immun 2008; 22:493-502.
29. Serebruany VL, Glassman AH, Malinin AI, et al. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) platelet substudy. Circulation 2003; 108:939-944.
30. van Zyl LT, Lesperance F, Frasure-Smith N, et al. Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Effi cacy Trial (CREATE) biomarker sub-study. J Thromb Thrombolysis 2009; 27:48-56.
31. Nijm J, Kristenson M, Olsson AG, et al. Impaired cortisol response to acute stressors in patients with coronary disease: implications for inflammatory activity. J Intern Med 2007; 262:375-384.
32. Hamer M, O'Donnell K, Lahiri A, Steptoe A. Salivary cortisol responses to mental stress are associated with coronary artery calcification in healthy men and women. Eur Heart J 2010; 31:424-429.
33. Ranjit N, Diez-Roux AV, Sanchez B, et al. Association of salivary cortisol circadian pattern with cynical hostility: multi-ethnic study of atherosclerosis. Psychosom Med 2009; 71:748-755.
34. Grant N, Hamer M, Steptoe A. Social isolation and stress-related cardiovascular, lipid, and cortisol responses. Ann Behav Med 2009; 37:29-37.
35. Jaffe IZ, Mendelsohn ME. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Circ Res 2005; 96:643-650.
36. Kubzansky LD, Adler GK. Aldosterone: a forgotten mediator of the relationship between psychological stress and heart disease. Neurosci Biobehav Rev 2010; 34:80-86.
37. Milliez P, Girerd X, Plouin PF, et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005; 45:1243-1248.
38. Duprez DA, Bauwens FR, De Buyzere ML, et al. Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension. Am J Cardiol 1993; 71:17A-20A.
39. Dawson N, Ferrington L, Olverman HJ, et al. Sex influences the effect of a lifelong increase in serotonin transporter function on cerebral metabolism. J Neurosci Res 2009; 87:2375-2385.